Triage, a recently instituted NIH practice in considering grant propos
als-whereby applications can be rejected after cursory review and with
out reply-is intended to save time as well as reduce the pressure on a
nd boost the morale of NIH reviewers. In reality, says pharmacology pr
ofessor Jose Musacchio, a former reviewer, little time would be saved
and it would be the researchers-specially young ones-who would be demo
ralized by the summary, unexplained rejections.